Transdermal iontophoresis. Part I: Basic principles and considerations

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 2, 1999, Pages 139-151

  Nair, Vinod ^a   Pillai, Omathanu ^a   Poduri, Ramarao ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Anodal iontophoresis; Cathodal iontophoresis; Current strength; Electroosmosis; Pulsed DC iontophoresis; Transdermal iontophoresis

Indexed keywords

CLONIDINE; ESTRADIOL; FENTANYL; FRANDO TAPE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NICOTINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

DEVICE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; HYDROPHILICITY; IONIC STRENGTH; IONTOPHORESIS; MATHEMATICAL MODEL; PHYSICAL CHEMISTRY; REVIEW; SKIN ABSORPTION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032926427     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.2.529241     Document Type: Review

References (90)

1. Cullander, C., Guy, R.H. Transdermal delivery of peptides and proteins: Routes of delivery: Case studies. Adv Drug Del Rev 1992, 8: 291-329.
2. Guy, R.H. Current status and future prospects of transdermal drug delivery. Pharm Res 1996, 13: 1765-9.
3. Panchagnula, R. Transdermal delivery of drugs. Ind J Pharmacol 1997, 29: 140-56.
4. Chien, Y.W., Banga, A.K. Iontophoretic (transdermal) delivery of drugs: Overview of historical development. J Pharm Sci 1989, 78: 353-4.
5. Leduc, S. Introduction of medicinal substances into the depth of tissues by electric current. Ann d'Electrobiol 1990, 3: 545-60.
6. Riviere, J.E., Heit, M.C. Electrically assisted transdermal drug delivery. Pharm Res 1997, 14: 687-97.
7. Tyle, P. Iontophoretic devices for drug delivery. Pharm Res 1986, 3: 318-26.
8. Green, P., Flanagan, M., Shroot, B., Guy, R.H. Iontophoretic drug delivery. In: Pharmaceutical Skin Penetration Enhancement. Walters, K.A., Hadgraft, J. (Eds.). Marcel Dekker: New York 1993, 311-33.
9. Jung, G., Katz, H., Schmitt, H., Voges, K.P., Menestrina, G., Boheim, G. Conformational requirements for the potential pore formation of peptide antibiotics alamethicin, suzukacillin and trichotoxin. In: Physical Chemistry of Transmembrane Ion Motion. Spach, G.(Ed.). Elsevier: New York, 1983.
10. Cullander, C., Guy, R.H. Sites of iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode. J Invest Dermatol 1991, 97: 55-64.
11. Jadoul, A., Regnier, V., Doucet, J., Durand, D., Preat, V. X-ray scattering analysis of human stratum corneum treated by high voltage pulses. Pharm Res 1997, 14: 1275-7.
12. Burnette, R.R., Ongpipattanakul, B. Characterization of the perms-elective properties of skin. J Pharm Sci 1987, 76: 765-73.
13. Pikal, M.J. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 1990, 7: 118-26.
14. Charro, M.B.D., Bayon, A.M.R., Guy, R.H. Iontophoresis of nafarelin: Effects of current density and concentration on electrotransport in vitro. J Control Rel 1995, 35: 35-40.
15. Pikal, M.J., Shah, S. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res 1990, 7: 213-21.
16. Pikal, M.J., Shah, S. Transport mechanism in iontophoresis, III. An experimental study of the contribution of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res 1990, 7: 222-9.
17. Pikal, M. Role of electroosmotic flow in transdermal iontophoresis. Adv Drug Del Rev 1992, 9: 201-37.
18. Lin, R.Y., Ou, Y.C., Chan, W.Y. The role of electroosmotic flow in vitro transdermal iontophoresis. J Control Rel 1997, 43: 23-33.
19. Hirvonen, J., Guy, R.H. Iontophoretic delivery across the skin. Electroosmosis and its modulation by drug substances. Pharm Res 1997, 14: 1258-63.
20. Hirvonen, J., Guy, R.H. Transdermal iontophoresis: Modulation of electroosmosis by polypeptides. J Control Rel 1998, 50: 283-9.
21. Rao, G., Glikfeld, P., Guy, R.H. Reverse iontophoresis: development of a non invasive approach for glucose monitoring. Pharm Res 1993, 10: 1751-5.
22. Rao, G., Guy, R.H., Glikfield, P., LaCourse, W.R., Leung , L., Tamada, J., Potts, R.O., Azimi, N. Reverse iontophoresis: Noninrasive glucose monitoring in vivo in humans. Pharm Res 1995, 12: 1869-73.
23. Guy, R.H. A sweeter life for diabetics. Nature Med 1995, 1: 1132-3.
24. Burnette, R. Transdermal drug delivery. In: Developmental Issues and Research Initiatives. Hadgraft, J., Guy, R.H. (Eds.). Marcel Dekker: New York 1989, 265-88.
25. Kasting, G.B., Keister, J.C. Application of electrodiffusion theory for a homogenous membrane to iontophoretic transport through skin. J Control Rel 1989, 18: 195-210.
26. Kasting, G.B. Theoretical models for iontophoretic delivery. Adv Drug Del Rev 1992, 9: 177-99.
27. Schlogl, R. Electrodiffusion in free solution and charged membranes. Z Pysik Chem N.F.I 1954, 305-39.
28. Keister, J.C., Kasting, G.B. The mechanism of iontophoresis. In: Proceedings of the Workshop on Current Status and Future Directions of Transdermal Delivery of Drugs. Higuchi, W.I., Sharma, D. (Eds.). US Department of health and human services: Bethesda, Maryland 1990, 137-54.
29. Inada, H., Mizuguchi, K., Katayama, K., Kakemi, M., Koizumi, Y. Two layer membrane model for iontophoretic drug transport through excised rat skin. Biol Pharm Bull 1993, 16: 589-93.
30. Burnette, R.R., Marrero, D. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci 1986, 75:738-43.
31. Yoshida, N.H., Roberts, M.S. Solute molecular size and transdermal iontophoresis across excised human skin. J Control Rel 1993, 25: 177-95.
32. Prausnitz, M.R. The effect of electric current applied to skin: A review for transdermal drug delivery. Adv Drug Del Rev 1996, 18: 395-425.
33. Chien, Y.W., Siddiqui, O., Sun, Y., Shi, W.M., Liu, J.C. Transdermal iontophoretic delivery of therapeutic peptides/proteins (I) Insulin. In: Biological Approaches in Controlled Delivery of Drugs. Juliano, R.L. (Ed.) Ann NY Acad Sci 1987, 507: 32-51.
34. Chien, Y.W., Siddiqui, O., Shi, W.M., Lelawongs, P., Liu, J.C. Direct current transdermal delivery of peptides and proteins drugs. J Pharm Sci 1989, 78: 376-83.
35. Groning, R. Etectrophoretically controlled dermal or transdermal application systems with electronic indicators. Int J Pharm 1987, 36: 37-40.
36. Okabe, K., Yamaguchi, H., Kawai, Y. New iontophoretic transdermal administration of the beta blocker metoprolol. J Control Rel 1986, 4: 79-85.
37. Chien, Y.W., Lelawongs, P., Siddiqui, O., Sun, Y., Shi, W.M. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J Control Rel 1990, 13: 263-78.
38. Gangarosa, L.P., Hill, J.M. Modern iontophoresis for local drug delivery. Int J Pharm 1995, 123: 159-71.
39. Siddiqui, O., Roberts, M.S., Polack, A.E. The effect of iontophoresis and vehicle pH on the in vitro permeation of lignocaine through human stratum corneum. J Pharm Pharmacol 1985, 37: 732-5.
40. Wearley, L., Liu, J.C., Chein, Y.W. Iontophoretic facilitated transdermal delivery of verapamil (I): In vitro evaluation and mechanistic studies. J Control Rel 1989, 8: 237-50.
41. Masada, T., Higuchi, W.I., Srinivasan, V., Rohr, V., Fox, J., Behl, C., Pons, S. Examination of iontophoretic transport of ionic drugs across skin: Baseline studies with the four electrode system. Int J Pharm 1989, 49: 57-62.
42. Bellantone, N.H., Rim, S., Francoeur, M.L., Rasadi, B. Enhanced percutaneous absorption via iontophoresis: I. Evaluation of an in vitro system and transport of model compounds. Int J Pharm 1986, 30: 63-72.
43. Glikfeld, P., Cullander, C., Hintz, R.S., Guy, R.H. A new system for in vitro studies of iontophoresis. Pharm Res 1988, 5: 443-6.
44. Huang, Y.Y., Wu, S.M., Wang, C.Y., Jiang, T.S. A strategy to optimize the operation of conditions in iontophoretic transdermal delivery of pilocarpine. Drug Dev Ind Pharm 1995, 21: 1631-48.
45. Gupta, S.K., Kumar, S., Bolton , S., Behl, C.R., Malick, A.W. Optimization of iontophoretic transdermal delivery of a peptide and a nonpeptide drug. J Control Rel 1994, 30: 253-61.
46. Del Terzo, S., Behl, C.R., Nash, R.A. Iontophoretic transport of a homologous series of ionized and non-ionized model compounds: Influence of hydrophobicity and mechanistic interpretation. Pharm Res 1989, 6: 85-90.
47. Siddiqui, O., Roberts, M.S., Polack, D.E. Iontophoretic transport of weak electrolytes through the excised human stratum corneum. J Pharm Pharmacol 1989, 41: 430-2.
48. Ahn, H. A., Shim, C.K., Kim, C.K. In vitro iontophoresis of isopropamide through rat skin and effect of ion pair formation with organic anions. J Control Rel 1993, 25: 205-15.
49. Rosendahl, T. Studies on the conducting properties of human skin to direct current. Acta Physiol Scand 1942-43, 5: 130-51.
50. Wearley, L., Chein, Y.W. Enhancement of the in vitro skin permeability of azidothymidine (AZT) via iontophoresis and chemical enhancer. Pharm Res 1990, 7: 34-40.
51. Lelawongs, P., Liu, J.C., Siddiqui, O., Chien, Y.W. Transdermal iontophoretic delivery of arginine-vasopressin: (I). Physicochemical considerations. Int J Pharm 1989, 56: 13-22.
52. Phipps, J.B., Padmanabhan, R.V., Lattin, G.A. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 1989, 78: 365-9.
53. Banga, A.K., Chien, Y.W. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J Control Rel 1988, 7: 1-24.
54. Sanderson, J.E., De Riel, S., Dixon, D. Iontophoretic delivery of nonpeptide drugs: Formulation optimization for maximum skin permeability. J Pharm Sci 1989, 78: 361-9.
55. Lelawongs, P., Liu, J.C., Chien, Y.W. Transdermal iontophoretic delivery of arginine-vasopressin (II): Evaluation of electrical and operational factors. Int J Pharm 1990 61: 179-88.
56. Singh, P., Maibach, H.I. Iontophoresis: an alternative to the use of carriers in cutaneous drug delivery. Adv Drug Del Rev 1996, 18: 379-94.
57. Brand, D.M., Guy, R.H. Iontophoresis of nicotine in vitro: Pulsatile drug delivery across the skin. J Control Rel 1995, 33: 285-92.
58. Singh, S., Jayswal, S.B., Singh, J. Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis. Int J Pharm 1998, 166: 157-66.
59. Lawler, J.C., Davis, M.J., Griffith, E. Electrical characteristic of the skin: The impedance of the surface sheath and deep tissues. J Invest Dermatol 1960, 34: 301-8.
60. Zazkewski, C.A., Li, J.K.J. Pulsed mode constant current iontophoresis transdermal metoprolol tartrate delivery in established acute hypertensive rabbits. J Control Rel 1991, 17: 157-62.
61. Chien, Y.W. Transdermal route of protein and peptide drug delivery. In: Peptide and Protein Drug Delivery. Lee, V.H. (Ed.). Marcel Dekker: New York 1991, 667-89.
62. Saraf, S., Dixit, V.K. Influence of electrical factors on in vitro iontophoretic delivery of timolol maleate. Drug Dev Ind Pharm 1996, 22: 175-9.
63. Bagniefski, T., Burnette, R. A comparison of pulsed and continuous current iontophoresis. J Control Rel 1990, 11: 113-22.
64. Liu, J.C., Sun, Y., Siddiqui, O., Chien, Y.W., Shi, W.M., Li, J. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin. Int J Pharm 1988, 44: 197-204.
65. Srinivasan, V., Higuchi, W.I., Su, M.H. Baseline studies with the four electrode system: the effect of skin permeability increase and water transport on the flux of a model uncharged solute during iontophoresis. J Control Rel 1989, 10: 157-65.
66. Behl, C.R., Kumar, S., Malick, A.W., Del Terzo, S., Higuchi, W.I., Nash, R.A. Iontophoretic drug delivery: effects of physicochemical factors on the skin uptake factors on the skin uptake of nonpeptide drugs. J Pharm Sci 1989, 78: 355-60.
67. Hirvonen, J., Kontturi, K., Murtomäki, L., Paronen, P., Urtti, A. Transdermal iontophoresis of sotalol and salicyalte: the effect of skin charge and penetration enhancers. J Control Rel 1993, 26: 109-17.
68. Hinsberg, W.H.M.C.V., Verhoef, J.C., Leo, J.B., Junginger, H.E., Bodde, H.E. Role of appendages in skin resistance and iontophoretic peptidt flux: human versus snake skin. Pharm Res 1995, 12: 1506-12.
69. Burnette, R.R., Ongpipattanakul, B. Characterization of the pore transport properties and tissue alteration of the excised human skin during iontophoresis. J Pharm Sci 1988, 77: 132-7.
70. Miller, L.L., Smith, G.A. Iontophoretic transport of acetate and carboxylate ions through hairless mouse skin: A cation exchange membrane model. Int J Pharm 1989, 49: 15-22.
71. Mathot, R., Srinivasan, V., Higuchi, W.I., Su, M.H., Sims, S.M. A model iontophoresis system for basic studies using millipore membranes. Proc Intern Symp Control Rel Bioact Mater 1989, 16: 52-3.
72. Siddiqui, O., Sun, Y., Liu, J.C., Chien, Y.W. Facilitated transport of insulin. J Pharm Sci 1987, 76: 341-5.
73. Stephen, R.L., Petelenz, T.J., Jacobsen , S.C. Potential novel methods for insulin administration: I. Iontophoresis. Biomed Biochem Acta 1984, 43: 553-8.
74. Riviere, N.A.M., Inman, A.O., Riviere, J.E. Identification of the pathway of iontophoretic drug delivery: Light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 1994, 11: 251-6.
75. Kari, B. Control of blood glucose levels in alloxan-diabetic rats by iontophoresis of insulin. Diabetes 1986, 35: 217-21.
76. Meyer, B.R., Katzeff, H.L., Eschbach, J., Trimmer, J.S., Zacharias, S.B., Rosen, S., Sibalis, D. Transdermal delivery of insulin to albino rats using electrical current. Am J Med Sci 1989, 297: 321-5.
77. Sanderson, J.E., Caldwell, R.W., Hsiao, J., Dixon, R., Tuttle, R.R. Non-invasive deliverv of novel iontophoretic catecholamine: Iontophoresis vs Intravenous infusion in dogs. J Pharm Sci 1987, 76: 215-8.
78. Meyer, B.R., Kries, W., Eschbach, J., O'Maro, V., Rosen, S., Sibalis, D. Successful transdermal administration of therapeutic doses of polypeptide to normal human volunteers. Clin Pharmacol Therap 1990, 44: 607-12.
79. Kasting, G.B., Bowman, L.A. DC electrical properties of frozen, excised human skin. Pharm Res 1990, 7: 134-43.
80. Riviere, J.E., Sage, B., Williams, P.L. Effects of vasoactive drugs on transdermal lidocaine iontophoresis. J Pharm Sci 1991, 80: 615-20.
81. Riviere, J.E., Riviere, N.A., Inman, A.O. Determination of lidocaine concentrations in skin after transdermal iontophoresis: Effect of vasoactive drugs. Pharm Res 1992, 9: 211-4.
82. Singh, P., Maibach, H.I. Iontophoresis in drug delivery: Basic principles and applications. Crit Rev Ther Drug Car Syst 1994, 11: 161-213.
83. Ledger, D.W. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Del Rev 1992, 9: 289-307.
84. Schwartz, V., Sutliffe, C.H., Style, P.P. Some hazards of the sweat test. Arch Dis Childh 1968, 43: 695-701.
85. Molitor, H., Fernandez, L. Studies on iontophoresis I: Experimental studies on the causes and prevention of iontophoretic burns. Am J Med Sci 1939, 198: 778-85.
86. Jarvis, C.H., Voitu, D.A. Low voltage skin burns. Pediatrics 1971, 48: 831-2.
87. Newton , R.A., Karselis, T.C. Skin pH following high voltage pulsed galvanic stimulation. Phys Ther 1983, 63: 1593-6.
88. Parasrampuria, D., Parasrampuria, J. Percutaneous delivery of proteins and peptides using iontophoretic technique. J Clin Pharm Therap 1991, 16: 7-17.
89. Gupta, S.K., Kumar, S., Bolton, S., Behl, C.R., Malick, A.W. Effect of chemical enhancers and conducting gets on iontophoretic transdermal delivery of cromolyn sodium. J Control Rel 1994, 31: 229-36.
90. Ganga, S., Ramarao, P., Singh, J. Effect of azone on the iontophoretic transdermal delivery of metoprolol tartarate through human epidermis in vitro. J Control Rel 1996, 42: 57-67.